Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Chlorhexidine gluconate, Isopropyl alcohol may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
ChloraPrep with Tint is a cutaneous solution of chlorhexidine gluconate and isopropyl alcohol in a plastic applicator with a sponge tip on one end. The applicator contains a fast acting antiseptic solution, which is used to disinfect the skin and help prevent infections before invasive medical procedures, such as injections, insertion of catheters and minor or major surgery. ChloraPrep with Tint contains a tint to colour the skin, which plays no role in the antiseptic properties of the solution. 2.
e ChloraPrep with Tint
Do not use ChloraPrep with Tint: if you are allergic (hypersensitive) to chlorhexidine gluconate or any of the other ingredients of ChloraPrep with Tint, especially if you have a history of possible chlorhexidine-related allergic reactions (listed in section 6). Warnings and precautions Talk to your doctor, pharmacist or nurse before using ChloraPrep with Tint. ChloraPrep with Tint is for external use only. ChloraPrep with Tint should not be used: near delicate linings (mucous membranes), as it may cause irritation. If it does get onto the delicate linings of the body passages, it should be washed quickly with plenty of water. on open skin wounds and broken or damage skin on the part of the ear that is inside the body (middle ear). in direct contact with neural tissue (for example brain and spinal cord tissue).
1
ChloraPrep with Tint must not come into contact with the eye due to the risk of visual damage. If it comes into contact with the eyes, wash out immediately and thoroughly with water. In case of any irritation, redness or pain in the eye, or visual disturbance, ask for medical advice promptly. Serious cases of persistent corneal injury (injury to the surface of the eye) potentially requiring corneal transplant have been reported when similar products have accidentally come in contact with the eye during surgical procedures, in patients under general anaesthesia (deep painless sleep). ChloraPrep with Tint may in rare cases cause severe allergic reactions, leading to a drop in blood pressure and even to unconsciousness. Early symptoms of a severe allergic reaction may be skin rash or asthma. If you notice these symptoms, stop using ChloraPrep with Tint and contact your doctor as soon as possible (see under section 4: "Possible side effects"). ChloraPrep with Tint should only be applied to the skin gently. When the solution is applied in an overvigorous manner to very fragile or sensitive skin or after repeated use, rash, inflammation, itching, dry and/or flaky skin and pain may occur. At the first sign of any of these reactions, application of ChloraPrep with Tint should be stopped. Prolonged skin contact should be avoided. Soaked materials, such as drapes or gowns should be removed before use. The solution should not be allowed to pool. The solution is flammable. Do not use ignition sources, naked flames or strong heat sources near the treated area until the skin is completely dry. Children Use with care in newborn babies, especially those born prematurely. ChloraPrep with Tint may cause chemical skin burns. Other medicines and ChloraPrep with Tint Tell your doctor, pharmacist or nurse if you have recently had a vaccine or skin test injection (patch test used to test for allergies). Pregnancy, breast-feeding and fertility There are no studies with ChloraPrep with Tint in pregnant or lactating women. Pregnancy No effects during pregnancy are anticipated, since systemic exposure to chlorhexidine gluconate is negligible. ChloraPrep with Tint can be used during pregnancy. Lactation No effects on the breastfed newborn/infant are anticipated since the systemic exposure of the breast-feeding woman to chlorhexidine gluconate is negligible. ChloraPrep with Tint can be used during breast-feeding. Fertility The effects of chlorhexidine gluconate on human reproduction have not been studied. Driving and using machines ChloraPrep with Tint does not affect your driving or ability to use machines. 3.
ChloraPrep with Tint
The antiseptic solution within the ChloraPrep with Tint system is kept inside the plastic applicator. Your doctor, pharmacist or nurse will select the applicator size based on the procedure site and area of skin to be covered. Your doctor or nurse will rub the sponge gently over your skin, covering the skin area that needs to be prepared. Depending on your medical procedure, more than one applicator may be used. 2
ChloraPrep with Tint is only used on the intact skin and each applicator is only used once. If you have any further questions on the use of this product, ask your doctor, pharmacist or nurse. 4.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If you experience any of the following reactions stop using ChloraPrep with Tint and get immediate medical help: swelling of the face, lips, tongue or throat; a red itchy skin rash; wheezing or difficulty breathing; feeling faint and dizzy; a strange metallic taste in the mouth; collapse. You may be having an allergic reaction. If you develop a rash or your skin becomes itchy, painful, red, blistery, dry or inflamed where you have used the product as a skin wash, stop using ChloraPrep with Tint and talk to your doctor, pharmacist or nurse. Very rarely (fewer than 1 in 10,000 people), allergic or irritated skin reactions to the ingredients in ChloraPrep with Tint (chlorhexidine gluconate, isopropyl alcohol and the tint Sunset Yellow E110) have been reported. Other possible side effects, for which it is not known how often they occur, are: eye irritation, pain, corneal injury (injury to the surface of the eye), and permanent eye damage including permanent visual impairment (following accidental ocular exposure during head, face and neck surgical procedures) in patients under general anaesthesia (deep painless sleep), chemical burns, and skin burns in newborns/infants. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via: Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store By reporting side effects you can help provide more information on the safety of this medicine. 5.
ChloraPrep with Tint
Keep this medicine out of the sight and reach of children. This medicine does not require any special temperature storage conditions. Store in the original package; applicator is sterile unless the seal is broken. Flammable. Avoid exposure of the container and contents to naked flames during use, storage or disposal. Do not use this medicine after the expiry date which is stated on the label or carton after EXP. The expiry date refers to the last day of that month. Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6.
What ChloraPrep with Tint contains –
The active substances are chlorhexidine gluconate and isopropyl alcohol.
3
1 mL solution contains 20 mg of chlorhexidine gluconate (20 mg/mL) and 0.70 mL of isopropyl alcohol (0.70 mL/mL). 1 applicator with 3 mL solution contains 60 mg of chlorhexidine gluconate (20 mg/mL) and 2.10 mL of isopropyl alcohol (0.70 mL/mL). 1 applicator with 10.5 mL solution contains 210 mg of chlorhexidine gluconate (20 mg/mL) and 7.35 mL of isopropyl alcohol (0.70 mL/mL). 1 applicator with 26 mL solution contains 520 mg of chlorhexidine gluconate (20 mg/mL) and 18.20 mL of isopropyl alcohol (0.70 mL/mL). –
The other ingredients are purified water and Sunset Yellow (E110).
What ChloraPrep with Tint looks like and contents of the pack The 3 mL and 10.5 mL applicators consist of a latex-free round foam sponge attached to a plastic barrel which holds a glass ampoule containing the antiseptic solution. The 26 mL applicator consists of a latex-free square foam sponge attached to a plastic barrel which holds two glass ampoules containing the antiseptic solution. The sterile applicators are individually packaged in a film. The packaging consists of a lidding material sealed to a polymeric film creating a "pouch-like" packet surrounding the applicator. Pack Sizes: 1 applicator containing 3 mL cutaneous solution. Multipacks containing 25 applicators each containing 3 mL cutaneous solution. 1 applicator containing 10.5 mL cutaneous solution. Multipacks containing 25 applicators each containing 10.5 mL cutaneous solution. 1 applicator containing 26 mL cutaneous solution. Not all pack sizes may be marketed Marketing Authorisation Holder and Manufacturer The Marketing Authorisation holder of ChloraPrep with Tint is Becton Dickinson UK Ltd 1030 Eskdale Road, Winnersh, Wokingham, RG41 5TS, United Kingdom Customer contact for adverse events or medical information inquiries: +44 800 043 7546 The Manufacturer of ChloraPrep with Tint is Insight Health Limited Unit A Bridgefields, Welwyn Garden City, Hertfordshire AL7 1RX United Kingdom BD Infection Prevention BV Erembodegem-Dorp 86 9320 Erembodegem Belgium
4
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom under the following names: Austria – ChloraPrep gefärbt 20 mg/ml + 0,7 ml/ml Lösung zur Anwendung auf der Haut Belgium – ChloraPrep coloré à 2 % p/v / 70 % v/v solution pour application cutanée Finland – ChloraPrep värillinen 0 mg/ml / 0,70 ml/ml liuos iholle France – CHLORAPREP COLORE, solution pour application cutanée Germany – ChloraPrep gefärbt Lösung zur Anwendung auf der Haut Ireland – ChloraPrep with Tint 2% w/v / 70% v/v cutaneous solution Italy – ChloraPrep con Colorante 2% p/v / 70% v/v soluzione cutanea Luxembourg – ChloraPrep coloré à 2 % p/v / 70 % v/v solution pour application cutanée Malta – ChloraPrep with Tint 2% w/v / 70% v/v cutaneous solution Netherlands – Getinte ChloraPrep 2% w/v / 70% v/v oplossing voor cutaan gebruik Norway – Chloraprep med farge 20 mg/ml + 0,70 ml/ml liniment, oppløsning Portugal – Chloraprep laranja 20 mg/ml (2% p/v) + 550 mg/ml (70% v/v) solução cutânea Sweden – Chloraprep färgad 20 mg/ml + 0,70 ml/ml kutan lösning UK – ChloraPrep with Tint 2% w/v / 70% v/v cutaneous solution This leaflet was last revised in 01/2026. Licence Number: PL 05920/0003 <—————————————————————————————————————————-The following information is intended for healthcare professionals only: ChloraPrep with Tint 2% w/v / 70% v/v cutaneous solution chlorhexidine gluconate / isopropyl alcohol Instructions for using ChloraPrep with Tint applicators: For cutaneous use. For external use only.
5
Precautions for Use:
6
The active substance in ChloraPrep with Tint is chlorhexidine gluconate, isopropyl alcohol.
Medicines with the same active substance, strength and form include: ChloraPrep Clear, ChloraPrep Swabstick. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for ChloraPrep with Tint, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
The medicinal product is to be used for disinfection of the skin prior to invasive medical procedures.
Posology
ChloraPrep with Tint may be used in all age groups and patient populations (see section on paediatric population, below).
Paediatric population
ChloraPrep with Tint should be used with care in newborn babies, especially those born prematurely (see also section 4.4, Special warnings and precautions for use).
Method of administration
For cutaneous use
One applicator is used containing 3 mL, 10.5 mL or 26 mL of the ChloraPrep with Tint alcoholic solution.
The choice of applicator will depend on the invasive procedure being undertaken and the clinician's preference.
Applicator
Coverage Area (cm x cm)
For Procedures such as:
3 mL
15 x 15
- Midline & Central Venous Catheter (CVC) insertion and maintenance
- Peritoneal dialysis site cleansing
10.5 mL
26 mL
25 x 30
50 x 50
- Minor and major surgical procedures
- Implantable device placement
- Prosthetic device placement or removal
- Midline, Peripheral Intravascular Central Catheter (PICC) & CVC insertion and maintenance
- Cardiac catheterisation and Cardiac Cath Lab procedures
- Interventional Radiology procedure
The applicator is removed from the wrapper and held with the sponge facing downward. The applicator is squeezed gently to break the ampoule containing the antiseptic solution, which is released onto the sponge in a controlled flow (for the 26 mL applicator the lever is pressed). Pinch wings once only to activate the applicator and release the antiseptic. Do not repeatedly pinch or pump the wings in an attempt to accelerate the saturation of the foam. The broken ampoule remains safely contained within the applicator. The sponge is gently pressed against the patient's skin in order to apply the antiseptic solution. Once the solution is visible on the skin, use gentle back and forth strokes to prepare the site for 30 seconds. The 26 mL applicator includes two swabs. The area covered should be allowed to air dry completely.
It is recommended that ChloraPrep with Tint remain on the skin post-procedure to provide continued antimicrobial activity. The tint will slowly fade from the skin. If removal is necessary, remove with soap and water or alcohol.
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, especially in those with a history of possible chlorhexidine-related allergic reactions (see sections 4.4 and 4.8).
The solution is flammable. Do not use electrocautery procedures or other ignition sources until the skin is completely dry.
Remove any soaked materials, drapes or gowns before proceeding with the intervention. Do not use excessive quantities of ChloraPrep with tint and do not allow the solution to pool in skin folds or under the patient or drip on sheets or other material in direct contact with the patient. Where occlusive dressings are to be applied to areas previously exposed to ChloraPrep with Tint, care must be taken to ensure no excess product is present prior to application of the dressing.
For external use only on intact skin.
ChloraPrep with Tint contains chlorhexidine. Chlorhexidine is known to induce hypersensitivity, including generalised allergic reactions and anaphylactic shock. The prevalence of chlorhexidine hypersensitivity is not known, but available literature suggests this is likely to be very rare. ChloraPrep with Tint should not be administered to anyone with a potential history of an allergic reaction to a chlorhexidine-containing compound (see sections 4.3 and 4.8). The solution is an irritant to mucous membranes. It should therefore be kept away from these areas.
ChloraPrep with Tint must not come into contact with the eye. Serious cases of persistent corneal injury, potentially requiring corneal transplant, were reported following accidental ocular exposure to chlorhexidine containing medicinal products despite taking eye protective measures due to migration of solution beyond the intended surgical preparation area. Extreme care must be taken during application to ensure that ChloraPrep with Tint does not migrate beyond its intended application site into the eyes. Particular care should be taken in anaesthetised patients, who are unable to immediately report ocular exposure. If ChloraPrep with Tint comes into contact with the eyes, wash out promptly and thoroughly with water. An ophthalmologist's advice should be sought.
Do not use on open skin wounds. Do not use on broken or damaged skin. In addition, direct contact with neural tissue or the middle ear must be avoided.
Prolonged skin contact with alcohol containing solutions should be avoided.
It is important to ensure that the correct method of application is strictly followed (see section 4.2 above). When the solution has been applied in an over-vigorous manner to very fragile or sensitive skin or after repeated use, local skin reaction may occur including: erythema or inflammation, itching, dry and/or flaky skin and local application site pain. At the first sign of local skin reaction, application of ChloraPrep with Tint should be stopped.
Anaphylactic reactions during anaesthesia
Chlorhexidine-containing products are known causes of anaphylactic reactions during anaesthesia.
The symptoms of anaphylactic reactions might be masked in an anesthetised patient e.g. a significant portion of skin may be covered or patient unable to communicate early symptoms.
If symptoms of an anaphylactic reaction are detected during anaesthesia (e.g. abrupt fall in blood pressure, hives, angioedema), chlorhexidine-related allergic reaction should be considered.
When chlorhexidine-related allergic reaction during anaesthesia is suspected, other products containing chlorhexidine used during anaesthesia (e.g. IV lines) should be removed. Special precaution should be taken to avoid patient exposure to any other product containing chlorhexidine during the course of the treatment.
Paediatric population
The use of chlorhexidine solutions, both alcohol-based and aqueous, for skin antisepsis prior to invasive procedures has been associated with chemical burns in neonates. Based on available case reports and the published literature, this risk appears to be higher in preterm infants, especially those born before 32 weeks of gestation and within the first 2 weeks of life.
Alcohol should not be brought into contact with some vaccines and skin test injections (patch tests). If in doubt, consult the vaccine manufacturer's literature.
There are no studies with this product in pregnant or lactating women.
Pregnancy
No effects during pregnancy are anticipated, since systemic exposure to chlorhexidine gluconate is negligible. ChloraPrep with Tint can be used during pregnancy.
Breastfeeding
No effects on the breastfed newborn/infant are anticipated since the systemic exposure of the breast-feeding woman to chlorhexidine gluconate is negligible. ChloraPrep with Tint can be used during breast-feeding.
Fertility
The effects of chlorhexidine gluconate on human reproduction have not been studied.
ChloraPrep with Tint has no or negligible influence on the ability to drive and use machines.
Skin and subcutaneous tissue disorders:
Very rarely (<1/10,000) allergic or irritation skin reactions have been reported with chlorhexidine, isopropyl alcohol and Sunset Yellow (E110) including: erythema, rash (e.g. erythematous, papular, or maculopapular), pruritus and blisters or application site vesicles. Other local symptoms have included skin burning sensation, pain and inflammation.
Frequency not known (cannot be estimated from the available data): dermatitis, eczema, urticaria, chemical burns in neonates.
Immune system disorders:
Frequency not known (cannot be estimated from the available data): Hypersensitivity including anaphylactic shock (see sections 4.3 and 4.4).
The most commonly reported adverse reactions reported are associated with application site reactions. These were noted to occur most often within the area of application of the solution (i.e. at the skin preparation site) and very rarely spread. The adverse reactions were often self-limiting in nature or resolved following treatment with topical steroids and / or antihistamines. The most commonly reported reactions were non-serious in nature and included application site rash, application site erythema, application site vesicles, application site pain and application site pruritus. Frequency, type and severity of adverse reactions in children are expected to be the same as in adults.
Cases of anaphylactic reactions have been reported during anaesthesia.
Eye disorders:
Frequency not known (cannot be estimated from the available data): Eye irritation, pain, hyperaemia, corneal erosion, epithelium defect/corneal injury, significant permanent visual impairment*.
*Cases of severe corneal erosion and permanent significant visual impairment due to inadvertent ocular exposure have been reported post-marketing, leading to some patients requiring corneal transplant (see section 4.4).
Description of selected adverse reactions
There have been isolated spontaneous reports of generalised allergic reactions potentially associated with ChloraPrep solution that have been reported during anaesthesia. In some cases, the patient may have had a pre-existing sensitivity to chlorhexidine (see Section 4.4).
This product may cause a severe allergic reaction. Symptoms may include wheezing/difficulty breathing, shock, facial swelling, hives, or rash. Use of ChloraPrep with Tint is contra-indicated where patients have shown previous hypersensitivity to chlorhexidine or isopropyl alcohol (see Section 4.3). If hypersensitivity or an allergic reaction occurs, stop use and seek medical help right away.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
There are no reports of overdose with this product.
Ask anything about ChloraPrep with Tint. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.